Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
490 INR | +0.03% | -1.94% | -18.66% |
May. 31 | Medicamen Biotech Receives Observations from Greek Regulatory Body; Shares Up 4% | MT |
May. 29 | Medicamen Biotech Limited Recommends Final Dividend for the Year 2023-24 | CI |
Sales 2022 | 1.15B 13.83M | Sales 2023 | 1.41B 16.88M | Capitalization | 8.29B 99.37M |
---|---|---|---|---|---|
Net income 2022 | 149M 1.79M | Net income 2023 | 148M 1.77M | EV / Sales 2022 | 7 x |
Net Debt 2022 | 220M 2.63M | Net Debt 2023 | 49.3M 591K | EV / Sales 2023 | 5.92 x |
P/E ratio 2022 |
52.8
x | P/E ratio 2023 |
55
x | Employees | 388 |
Yield 2022 |
0.16% | Yield 2023 |
0.15% | Free-Float | 40.23% |
1 day | +1.17% | ||
1 week | -2.15% | ||
Current month | -2.15% | ||
1 month | -2.04% | ||
3 months | +3.79% | ||
6 months | -19.35% | ||
Current year | -18.68% |
Managers | Title | Age | Since |
---|---|---|---|
Rajesh Madan
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | - | 18-07-24 | |
Aneek Gupta
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sanjay Bansal
BRD | Director/Board Member | 59 | 93-12-21 |
Rajesh Madan
CEO | Chief Executive Officer | - | - |
Director/Board Member | 62 | 19-02-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 490 | +0.03% | 2 359 |
24-06-07 | 489.9 | +1.17% | 5,359 |
24-06-06 | 484.2 | +4.49% | 3,724 |
24-06-05 | 463.4 | +2.23% | 2,802 |
24-06-04 | 453.4 | -9.28% | 3,655 |
Delayed Quote Bombay S.E., June 07, 2024 at 06:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-18.68% | 74.59M | |
+19.64% | 43.3B | |
+23.67% | 22.22B | |
+18.92% | 15.43B | |
+20.14% | 14.48B | |
+53.19% | 12.72B | |
-0.05% | 6.79B | |
-10.65% | 6.71B | |
-8.87% | 5.73B | |
+14.68% | 5.5B |
- Stock Market
- Equities
- 531146 Stock